An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer’s Disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Alzheimer's Disease Année : 2016

An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer’s Disease

Fichier non déposé

Dates et versions

hal-01922572 , version 1 (14-11-2018)

Identifiants

Citer

Yamila Rodríguez Cruz, Manon Strehaiano, Teresita Rodríguez Obaya, Julío César García Rodríguez, Tangui Tm Maurice. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease, 2016, 55 (1), pp.231 - 248. ⟨10.3233/JAD-160500⟩. ⟨hal-01922572⟩
54 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More